t-CUPM

N/A

Report date: 2021/11/26 17:52:17
NME

Base Information

Drug Namet-CUPM
Drug Alias Namec-Raf/soluble epoxide hydrolase inhibitor (cancer)(Northwestern University/University of California)t-CUPM
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpoxide hydratase inhibitorsRAF serine/threonine protein kinase inhibitors
TargetsEpoxide hydrataseRAF serine/threonine protein kinase
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of CaliforniaNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesNorthwestern University
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A